Patents by Inventor Houn Simon Hsia

Houn Simon Hsia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896624
    Abstract: A composition for decreasing proliferation of cancer cells undergoing hyperthermia therapy is described. Such compositions can include a combination of selenium and fish oil. The respective quantities of selenium and fish oil are provided in amounts effective to synergistically increase the sensitivity of the cancer cells to temperatures in excess of 37° C.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: February 13, 2024
    Inventor: Houn Simon Hsia
  • Patent number: 11872252
    Abstract: Compositions and methods are provided in which a nutritional supplement that is utilized in the treatment viral infections (e.g., coronavirus, HCV, HIV), by correcting dysregulation of apoptosis, reducing production of pro-inflamatory cytokines, and increasing production of host anti-viral compounds. The nutritional supplements can be used in combination with known antiviral therapies, as well as low level radiotherapy and/or chemotherapy drugs conventionally used in the treatment of neoplastic disease.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: January 16, 2024
    Inventor: Houn Simon Hsia
  • Publication number: 20230285471
    Abstract: Compositions and methods are provided in which a nutritional supplement that is utilized in the treatment viral infections (e.g., coronavirus, HCV, HIV), by correcting dysregulation of apoptosis, reducing production of pro-inflammatory cytokines, and increasing production of host anti-viral compounds. The nutritional supplement can be used in combination with known antiviral therapies, as well as low level radiotherapy and/or chemotherapy drugs conventionally used in the treatment of neoplastic disease.
    Type: Application
    Filed: August 10, 2021
    Publication date: September 14, 2023
    Inventor: Houn Simon HSIA
  • Publication number: 20230124019
    Abstract: A nutritional supplement containing fish oil and selenium has been identified that reduces angiogenesis and/or stem cell content of tumors. A formulation for such a supplement that is both well tolerated and palatable is also provided.
    Type: Application
    Filed: November 14, 2022
    Publication date: April 20, 2023
    Inventor: Houn Simon Hsia
  • Publication number: 20230113424
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.
    Type: Application
    Filed: December 12, 2022
    Publication date: April 13, 2023
    Inventor: Houn Simon HSIA
  • Patent number: 11576940
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.
    Type: Grant
    Filed: February 18, 2022
    Date of Patent: February 14, 2023
    Inventor: Houn Simon Hsia
  • Patent number: 11541079
    Abstract: A nutritional supplement containing fish oil and selenium has been identified that enhances immunotherapy of tumors, particularly in regard to reducing PDL-1 expression. A formulation for such a supplement that is both well tolerated and palatable is also provided.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: January 3, 2023
    Inventor: Houn Simon Hsia
  • Publication number: 20220354903
    Abstract: A composition for decreasing proliferation of cancer cells undergoing hyperthermia therapy is described. Such compositions can include a combination of selenium and fish oil. The respective quantities of selenium and fish oil are provided in amounts effective to synergistically increase the sensitivity of the cancer cells to temperatures in excess of 37° C.
    Type: Application
    Filed: July 27, 2022
    Publication date: November 10, 2022
    Inventor: Houn Simon HSIA
  • Patent number: 11433105
    Abstract: A method for decreasing proliferation of cancer cells comprises the steps of administering a sensitizer. Sensitizers can include selenium, fish oil, and a combination of selenium and fish oil to a cancer cell. The method contemplates that the selenium and fish oil are administered in an amount effective to respectively increase the sensitivity of the cancer cells, and the administration of the combination of selenium and fish oil are administered in an amount effective to synergistically increase the sensitivity of the cancer cells more than the selenium or the fish oil alone. The method additionally exposes cancer cells to temperatures in excess of 37° C.
    Type: Grant
    Filed: January 30, 2021
    Date of Patent: September 6, 2022
    Inventor: Houn Simon Hsia
  • Publication number: 20220175850
    Abstract: Compositions and methods are described in which a nutritional supplement (such as a supplement that includes chromium and certain plant-derived materials and/or a supplement that includes a selenium yeast peptide complex and fish oil is used to provide an immunotherapeutic effect, which can be demonstrated by modulation of cell-surface markers targeted by conventional immunotherapeutic drugs. The nutritional supplements can be used in combination with other antineoplastic therapies, such as radiation and/or chemotherapeutic agents. Such combination therapy can provide a synergistic effect in regard to modulation of cell surface markers that serve as immunotherapy targets.
    Type: Application
    Filed: March 31, 2020
    Publication date: June 9, 2022
    Inventor: Houn Simon Hsia
  • Publication number: 20220168369
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.
    Type: Application
    Filed: February 18, 2022
    Publication date: June 2, 2022
    Inventor: Houn Simon HSIA
  • Publication number: 20220095667
    Abstract: A nutritional supplement is described that is useful in combination with radiotherapy to reduce the growth of tumor stem cells. The nutritional supplement includes selenium and fish oil, and has been also found to be effective in reducing negative side effects of concurrent radiotherapy, including inflammation, weight loss, muscle wasting, neutropenia, and loss of cells from the lining of the gut.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 31, 2022
    Inventor: Houn Simon Hsia
  • Patent number: 11253561
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: February 22, 2022
    Inventor: Houn Simon Hsia
  • Patent number: 11206861
    Abstract: A nutritional supplement is described that enhances and provides synergistic effects when used in combination with radiotherapy to treat tumors, both reducing tumor size and preventing metastasis. The nutritional supplement has been also found to be effective in reducing negative side effects of concurrent radiotherapy, including inflammation, weight loss, muscle wasting, neutropenia, and loss of cells from the lining of the gut.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: December 28, 2021
    Inventor: Houn Simon Hsia
  • Publication number: 20210283205
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 16, 2021
    Inventor: Houn Simon HSIA
  • Publication number: 20210252076
    Abstract: A nutritional supplement that includes fish oil and selenium has been found to provide a variety of activities beneficial in treating cancer and associated conditions. Such a supplement provides synergistic effects in reducing cancer cell proliferation when used in combination with chemotherapeutic drugs, and can reduce proliferation in drug-resistant cancer cells when used in combination with chemotherapeutic drugs to which the cells are resistant. Effects in reducing angiogenesis, reducing metastasis, reducing the number of circulating cancer cells, and modifying AXL signaling were also found. In addition, use of such a supplement was found to reduce wasting associated with cachexia and reduce circulating cytokines associated with inflammation. Overall effects were found to extend survival in clinical studies.
    Type: Application
    Filed: February 1, 2021
    Publication date: August 19, 2021
    Inventor: Houn Simon Hsia
  • Publication number: 20210213071
    Abstract: A nutritional supplement containing fish oil and selenium has been identified that enhances immunotherapy of tumors, particularly in regard to reducing PDL-1 expression. A formulation for such a supplement that is both well tolerated and palatable is also provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: July 15, 2021
    Inventor: Houn Simon Hsia
  • Publication number: 20210154241
    Abstract: A method for decreasing proliferation of cancer cells comprises the steps of administering a sensitizer. Sensitizers can include selenium, fish oil, and a combination of selenium and fish oil to a cancer cell. The method contemplates that the selenium and fish oil are administered in an amount effective to respectively increase the sensitivity of the cancer cells, and the administration of the combination of selenium and fish oil are administered in an amount effective to synergistically increase the sensitivity of the cancer cells more than the selenium or the fish oil alone. The method additionally exposes cancer cells to temperatures in excess of 37° C.
    Type: Application
    Filed: January 30, 2021
    Publication date: May 27, 2021
    Inventor: Houn Simon Hsia
  • Patent number: 10946052
    Abstract: The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium, chromium, and molybdenum in c combination with a fish oil.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: March 16, 2021
    Inventor: Houn Simon Hsia
  • Patent number: 10905723
    Abstract: A nutritional supplement containing fish oil and selenium has been identified that potentiates radiotherapy of tumors in a synergistic fashion. Cotherapy with such a supplement and radiotherapy results in substantially improved reductions in tumor volume of animal models relative to radiotherapy alone, and reduces common side effects such as weight loss, inflammation, and damage to the gastrointestinal tract. Such cotherapy was also found to reduce the incidence of metastasis from the primary implantation site, and to modulate expression of genes associated with apoptosis in tumor cells. A formulation for such a supplement that is both well tolerated and palatable is also provided.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: February 2, 2021
    Inventor: Houn Simon Hsia